Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,823 | 244 | 99.9% |
| Education | $11.26 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,439 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,065 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,959 | 87 | $0 (2022) |
| Lilly USA, LLC | $560.21 | 15 | $0 (2024) |
| Novo Nordisk Inc | $505.70 | 13 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $339.20 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $205.38 | 10 | $0 (2024) |
| AbbVie, Inc. | $144.22 | 2 | $0 (2017) |
| PFIZER INC. | $123.38 | 6 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $122.25 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $674.25 | 16 | AstraZeneca Pharmaceuticals LP ($201.33) |
| 2023 | $1,246 | 19 | AstraZeneca Pharmaceuticals LP ($512.41) |
| 2022 | $1,158 | 30 | Janssen Pharmaceuticals, Inc ($320.21) |
| 2021 | $1,716 | 58 | Janssen Pharmaceuticals, Inc ($771.74) |
| 2020 | $756.16 | 37 | Janssen Pharmaceuticals, Inc ($354.70) |
| 2019 | $1,263 | 37 | Janssen Pharmaceuticals, Inc ($512.82) |
| 2018 | $853.24 | 22 | AstraZeneca Pharmaceuticals LP ($472.01) |
| 2017 | $1,167 | 27 | GlaxoSmithKline, LLC. ($538.83) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 3 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Cardio-renal | ||||||
| 03/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $116.82 | General |
| Category: Diabetes | ||||||
| 03/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $105.07 | General |
| Category: Cardio-renal | ||||||
| 02/23/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $95.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Diabetes | ||||||
| 01/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Gastroenterology | ||||||
| 01/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $120.30 | General |
| Category: Cardio-renal | ||||||
| 12/02/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Cardio-renal | ||||||
| 12/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKAMET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $72.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $83.39 | General |
| Category: Gastroenterology | ||||||
| 11/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 531 | 975 | $96,543 | $57,514 |
| 2022 | 12 | 768 | 1,246 | $111,715 | $67,329 |
| 2021 | 10 | 760 | 1,227 | $107,261 | $65,099 |
| 2020 | 17 | 939 | 1,618 | $147,660 | $80,496 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 484 | $70,180 | $41,068 | 58.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $9,256 | $7,200 | 77.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 54 | $5,400 | $3,132 | 58.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 44 | 44 | $4,400 | $2,443 | 55.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 139 | 238 | $2,856 | $1,999 | 70.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $690.00 | $676.20 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 23 | 23 | $690.00 | $470.58 | 68.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 29 | $2,175 | $324.48 | 14.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 27 | 28 | $896.00 | $199.98 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 487 | $70,615 | $43,124 | 61.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $10,146 | $8,087 | 79.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 97 | $9,700 | $4,793 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 94 | 98 | $2,940 | $2,885 | 98.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 92 | 92 | $3,220 | $2,757 | 85.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 53 | 53 | $5,300 | $2,545 | 48.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,665 | $1,389 | 52.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 146 | 264 | $3,168 | $782.73 | 24.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $390.00 | $384.60 | 98.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 37 | 37 | $2,775 | $357.77 | 12.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 21 | 23 | $736.00 | $182.50 | 24.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 12 | $60.00 | $41.03 | 68.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 492 | $71,010 | $42,504 | 59.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 55 | 55 | $9,790 | $7,879 | 80.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 102 | $10,100 | $6,024 | 59.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 50 | 50 | $5,000 | $3,128 | 62.6% |
About Dr. Vernon Phillips, MD
Dr. Vernon Phillips, MD is a Family Medicine healthcare provider based in Imperial Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427062918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vernon Phillips, MD has received a total of $8,834 in payments from pharmaceutical and medical device companies, with $674.25 received in 2024. These payments were reported across 246 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($8,823).
As a Medicare-enrolled provider, Phillips has provided services to 2,998 Medicare beneficiaries, totaling 5,066 services with total Medicare billing of $270,439. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Imperial Beach, CA
- Active Since 07/28/2006
- Last Updated 08/11/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1427062918
Products in Payments
- XARELTO (Drug) $1,610
- FARXIGA (Drug) $1,037
- TRELEGY ELLIPTA (Drug) $884.91
- INVOKANA (Drug) $349.82
- AREXVY (Drug) $340.05
- Kerendia (Drug) $339.20
- BREZTRI (Drug) $322.23
- ANORO ELLIPTA (Drug) $284.83
- MOUNJARO (Drug) $275.39
- SYMBICORT (Drug) $240.55
- RYBELSUS (Drug) $238.45
- ANORO (Drug) $218.72
- Ozempic (Drug) $178.80
- TRULICITY (Drug) $162.84
- JARDIANCE (Drug) $159.70
- AIRSUPRA (Drug) $151.49
- MOVANTIK (Drug) $125.00
- INCRUSE (Drug) $124.99
- BREO (Drug) $124.63
- Viekira (Drug) $122.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Imperial Beach
Parmela Sawhney, M.d, M.D
Family Medicine — Payments: $4,600
Leonor Ordonez, Md, MD
Family Medicine — Payments: $218.43
Mrs. Danielle Gordon, Fnp, FNP
Family Medicine — Payments: $217.53
Danielle Richardson, M.d, M.D
Family Medicine — Payments: $151.82
Eric Leute, Md, MD
Family Medicine — Payments: $68.86
Faith Chisum, Md, MD
Family Medicine — Payments: $13.97